June 21, 2014 11:34 AM

12 0


The Food and Drug Administration (FDA) safety communication says that oncologists should look for intoxication-like symptoms in cancer patients, who have been prescribed intravenous docetaxel.

The FDA issued the safety guidelines as there were some reports that patients displayed intoxication-like symptoms after taking docetaxel.

Also read: FDA expands approval for Pfizer cancer drug Sutent

Read more

To category page